Growth Metrics

Merck (MRK) Enterprise Value Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 38.35%
Dec 31, 2025 -6.45%
Sep 30, 2025 -24.92%
Jun 30, 2025 24.21%
Mar 31, 2025 -64.83%
Dec 31, 2024 -93.64%
Sep 30, 2024 -66.70%
Jun 30, 2024 -78.35%
Mar 31, 2024 46.11%
Dec 31, 2023 46.37%
Sep 30, 2023 22.03%
Jun 30, 2023 37.04%
Mar 31, 2023 -16.46%
Dec 31, 2022 -63.59%
Sep 30, 2022 -12.42%
Jun 30, 2022 -18.54%
Mar 31, 2022 -28.62%
Dec 31, 2021 -0.75%
Sep 30, 2021 -36.78%
Jun 30, 2021 22.91%
Mar 31, 2021 6.13%
Dec 31, 2020 23.11%
Sep 30, 2020 8.31%
Jun 30, 2020 -57.09%
Mar 31, 2020 15.35%
Dec 31, 2019 -19.27%
Sep 30, 2019 21.09%
Jun 30, 2019 4.81%
Mar 31, 2019 -21.85%
Dec 31, 2018 -5.06%
Sep 30, 2018 37.37%
Jun 30, 2018 46.75%
Mar 31, 2018 50.56%
Dec 31, 2017 41.47%
Sep 30, 2017 -24.84%
Jun 30, 2017 -17.64%
Mar 31, 2017 -11.97%
Dec 31, 2016 -5.89%
Sep 30, 2016 -7.14%
Jun 30, 2016 -5.05%
Mar 31, 2016 16.84%
Dec 31, 2015 14.38%
Sep 30, 2015 15.58%
Jun 30, 2015 15.54%
Mar 31, 2015 13.81%
Dec 31, 2014 -4.36%
Sep 30, 2014 8.80%
Jun 30, 2014 14.56%
Mar 31, 2014 -37.62%
Dec 31, 2013 -8.96%
Sep 30, 2013 10.24%
Jun 30, 2013 -3.49%
Mar 31, 2013 0.67%
Dec 31, 2012 -9.18%
Sep 30, 2012 -42.68%
Jun 30, 2012 -29.56%
Mar 31, 2012 -24.00%
Dec 31, 2011 -28.39%
Sep 30, 2011 -48.94%
Jun 30, 2011 -53.88%
Mar 31, 2011 -44.61%
Dec 31, 2010 -36.16%
Sep 30, 2010 63.37%
Jun 30, 2010 45.86%
Mar 31, 2010 -21.52%